Resource Library
Pamir opinion: U.S.-China competition in building critical elements supply chains intensifies
Growing commercial and government concerns are intensifying U.S. efforts to diversify its critical minerals and rare earth elements supply chains as it’s far too reliant on imports, particularly from China.
The forthcoming U.S. BIOSECURE Act is already making an impact on the China business strategy of global pharmaceutical companies. What are the implications for your China risk exposure?
Biopharmaceutical companies worldwide have expressed their intentions to continue investing in China. However, the forthcoming U.S. BIOSECURE Act means that many are proactively reassessing their China business strategies. Pamir has been working with pharma
Rising US Concerns Over China Challenge in US-Mexico Trade Relations
As US-Mexico trade increases, Washington’s concerns that Mexico serves as a transit point for Chinese goods to the US are rising.
Japan and the European Union agree closer cooperation to develop advanced materials as they look to de-risk from Chinese supply chains
Japan and Europe rely on Chinese advanced materials to produce semiconductors, electronics, and even renewable energy equipment.
The search is on for ‘next generation’ specialized AI chips
As an extension of the on-going semiconductor trade wars between the West and China, the search is now on for next-gen AI chips that offer much greater processing power and speed, and significantly lower energy consumption.
U.S. and China open high-level talks on AI use and risks
Top officials from Washington and Beijing meet for the first time in Geneva to share their mutual concerns about each other’s use of artificial technologies (AI).
The U.S. government pushes the Netherlands, Japan, Germany, and South Korea to extend existing chip-making export bans, but faces resistance
Washington is in talks with the Netherlands and Japan to tighten restrictions on the export of advanced chips and chip-making equipment and materials to China. It is also seeking to bring in Germany and South Korea.
China Opposes US Army Deployment of Typhon Missile System
China’s increasingly assertive behavior in the South China Sea prompted the US to deploy more advanced weapons systems to the Philippines and conduct high-profile military exercises with Indo-Pacific allies and partners.
IP Theft: Assessing Insider Risk
A Chinese ex-Google software engineer, Linwei Ding, has been arrested for allegedly stealing over 500 sensitive files containing Intellectual Property (IP) about the company’s cutting-edge Machine Learning (ML) platform and the (AI) models it supports.
Bilateral Tensions Persist Despite US Secretary Blinken’s China Visit
US Secretary of State Antony Blinken’s recent visit to China did not resolve fundamental differences on key issues between the US and China.
Assessing the Chinese biotech supply chain risk: Proposed Biosecurity Act targets four Chinese biotech companies deemed to be U.S. national security concern
The proposed Biosecurity Act has been advanced to the Senate floor and specifically targets four Chinese biotech firms – WuXi AppTec, WuXi Bio, BGI Genomics, and MGI and its San Jose-Based subsidiary, Complete Genomics – from accessing U.S. funding and contracts with domestic biotech and pharma firms.
China’s Overcapacity Risks Strain US-China Relations and Global Economy
Pamir assesses that strong disagreements between Washington and Beijing will persist on the risks China’s excess capacity poses to US-China relations and the global economy.
China Challenge Intensifies US-Japan-Philippines Cooperation
The United States and two major Indo-Pacific allies – Japan and the Philippines – are intensifying diplomatic and military cooperation in direct response to China’s “strategic challenge.”
US-China Tensions Persist Despite Biden-Xi Call
Pamir observes that US and Chinese official readouts indicate that fundamental disagreements on priority issues – Taiwan, the South China Sea, trade, and technology –continue to strain the relationship. US-China relations are likely to remain turbulent for the rest of 2024.
China’s Position on Hamas-Israel War
On 7 October 2023, Hamas launched a major terrorist attack against Israel. Israel retaliated with massive military actions in Gaza, which have resulted in huge civilian casualties and a humanitarian crisis. As the Hamas-Israel war escalated, China took a seemingly neutral position by refusing to denounce Hamas but stating instead that China opposes attacks on civilians by any party.